Short Interest in MDB Capital Holdings, LLC (NASDAQ:MDBH) Drops By 31.5%

MDB Capital Holdings, LLC (NASDAQ:MDBH) saw a large drop in short interest in the month of March. As of March 31st, there was short interest totaling 4,239 shares, a drop of 31.5% from the March 15th total of 6,192 shares. Approximately 0.1% of the company’s stock are sold short. Based on an average daily trading volume, of 3,339 shares, the short-interest ratio is presently 1.3 days.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of MDB Capital in a research report on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, MDB Capital presently has a consensus rating of “Sell”.

Hedge Funds Weigh In On MDB Capital

Several institutional investors have recently modified their holdings of the business. Citadel Advisors LLC bought a new stake in MDB Capital during the third quarter worth $43,000. DRW Securities LLC bought a new position in MDB Capital in the 4th quarter valued at $40,000. Finally, Raymond James Financial Inc. purchased a new stake in shares of MDB Capital during the 2nd quarter valued at $27,000. 0.35% of the stock is owned by institutional investors.

MDB Capital Trading Up 1.4%

NASDAQ MDBH traded up $0.05 during trading hours on Thursday, hitting $3.56. The company’s stock had a trading volume of 1,533 shares, compared to its average volume of 6,878. MDB Capital has a 52 week low of $2.75 and a 52 week high of $5.50. The company has a market capitalization of $36.67 million, a PE ratio of -1.67 and a beta of 0.93. The company’s 50-day simple moving average is $3.11 and its two-hundred day simple moving average is $3.38.

MDB Capital (NASDAQ:MDBH) last issued its quarterly earnings data on Tuesday, March 31st. The company reported ($0.18) EPS for the quarter.

About MDB Capital

MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates through two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer that focuses on conducting private and public securities offerings, as well as providing research services for investment banking due diligence. The Technology Development segment engages in the synthetic biology technology development business.